Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study.

Diego Lopez-MenaMiguel García-GrimshawSergio Saldivar-DávilaLaura Elena Hernandez-VanegasMaría Del Mar Saniger-AlbaAlonso Gutiérrez-RomeroRoger Carrillo-MezoHector Eduardo Valdez-RuvalcabaVanessa Cano-NigendaFernando Daniel Flores-SilvaCarlos Cantú-BritoAna María Santibañez-CopadoJose-Luis Diaz-OrtegaSanta Elizabeth Ceballos-LiceagaLuis Manuel Murillo-BonillaAna Isabel Sepulveda-NúñezVerónica García-TalaveraEduardo Gonzalez-GuerraRicardo Cortes-AlcalaHugo Lopez-GatellGuillermo Carbajal-SandovalGustavo Reyes-TeránSergio Iván Valdés-FerrerAntonio Arauz

Published in: Neurology (2022)

Stroke is an exceedingly rare AEFI against SARS-CoV-2. Preexisting stroke risk factors were identified in most patients. Further research is needed to evaluate causal associations between SARS-COV-2 vaccines and stroke.

Keyphrases

sars cov
atrial fibrillation
risk factors
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
chronic kidney disease
cerebral ischemia
patient reported outcomes
coronavirus disease
brain injury
subarachnoid hemorrhage